Make.
Make Perfect.
Repeat.

New Zealand’s leading technology partner for human and animal applications. We work with innovators who are looking for an end to end solution provider that can support them through the entire process of R&D, product development, clinical trials, manufacture and commercialisation.

Make.
Make Perfect.
Repeat.

New Zealand’s leading technology partner for human and animal applications. We work with innovators who are looking for an end to end solution provider that can support them through the entire process of R&D, product development, clinical trials, manufacture and commercialisation.

The Journey
from Idea to Market

We guide innovators through their journey to market. With over 80 years of experience in human and animal health-related innovation and manufacturing, we’re here to collaborate to bring ideas to life, and to market. This is about partnerships. From conception to prototyping; R&D to product realisation; clinical trial to commercialisation.

DEC seeks partnerships
to build tomorrow’s
MedTech pipeline

DEC is seeking innovative partners with novel ideas to feed tomorrow’s MedTech and Controlled Release pipeline. Now is a unique moment for innovators with early-stage medical technologies, looking for support to bridge your product into the hands of those who will use them.

Our technical teams specialise in high-end technical injection moulding; and in the research, development, manufacturing and commercialisation of innovative technologies and solutions for human and animal health.

Medical
Devices

Specialised in ISO 13485 compliant product design and manufacture, DEC will assist to develop your medical device, mould plastic components, and assemble the product.

Pharmaceutical

We are the world’s most prolific controlled release implant manufacturer (10m implants, exported to 56 countries). We will guide your drug delivery innovation from concept to commercial scale GMP product.

Moulded
Components

Scalable product design and manufacture with automated injection moulding producing parts for some of New Zealand’s most well-known brands. 10 million parts produced monthly to high specification.

Agritech

Scalable product design and manufacture with automated injection moulding, filling, and component assembly. Different Quality compliance structures are available, which lets you control costs.

Medical
Devices

Specialised in ISO 13485 compliant product design and manufacture, DEC will assist to develop your medical device, mould plastic components, and assemble the product.

Pharmaceutical

We are the world’s most prolific controlled release implant manufacturer (10m implants, exported to 56 countries). We will guide your drug delivery innovation from concept to commercial scale GMP product.

Moulded
Components

Scalable product design and manufacture with automated injection moulding producing parts for some of New Zealand’s most well-known brands. 10 million parts produced monthly to high specification.

Agritech

Scalable product design and manufacture with automated injection moulding, filling, and component assembly. Different Quality compliance structures are available, which lets you control costs.

  • Case Study 1

    In-vitro diagnostics

    The Customer

    A start-up with novel in-vitro, ELISA technology.

    The Project

    A New Zealand based start-up needed consumables manufacturing for their novel ELISA technology, requiring single-use product design, plastic component moulding, and assembly.

    The Outcome

    DEC carried out a gap analysis to ensure the design process was ISO 13485 compliant, a critical step for later medical device registration applications. Design verification and validation was completed, followed by process development for cost-driven assembly. Small-scale manufacturing batches then supported the start-up’s clinical program as they looked to understand the end-user experience before a design freeze, and regulatory submissions.

  • Case Study 2

    Slow release implant delivery system

    The Customer

    Controlled release technology partner.

    The Project

    A range of implant delivery devices were needed for a family of controlled drug eluting implants for vet application.

    The Outcome

    DEC team provided end-to-end service including anatomical planning, product development, prototyping, design for manufacture, tooling, plastics injection moulding, and assembly to ISO 13485. Manufacturing scale was gradual, and DEC made use of our small-medium volume manufacturing facility at the early stages.

  • Case Study 3

    CIDR: Controlled Hormone Release in Livestock Herds

    The Customer

    Zoetis, a multinational animal and healthcare company.

    The Project

    Over 10 years, DEC’s partnership with Zoetis has seen sales of our EAZI-Breed CIDR devices increase from 2.5million to 10million, sold in 56 countries worldwide. This partnership needed scalable manufacture in order to achieve this market share, while driving down the CoGs (cost of goods).

    The Outcome

    DEC provided comprehensive value-stream mapping, in order to deliver a strategic process scale-up plan. Following this, process development then saw a 15x scale-up, and directly targeted a number of key bottlenecks. The output was increased manufacturing scale, while maintaining quality. Finally, DEC delivered process validations and technical documentation which were submitted for regulatory approval.

  • Case Study 4

    Slow release local anaesthetic for pain management

    The Customer

    Academic and clinical innovators who had co-developed a novel controlled local analgesic delivery device.

    The Project

    Our customers had identified an opportunity for post-surgical pain management using controlled local anaesthetic delivery, rather than systemic, opiate delivery. Their patented formulation allowed increased drug loading, and a novel format. They had a defined formulation and implant geometry, had completed encouraging animal trials, and were ready to commence a clinical program.

    The Outcome

    DEC worked with the partner to establish user requirements, then executed a technology transfer into DEC’s R&D division. Process and analytical development provided a scalable minimum viable product (MVP), which was then manufactured for first in man, with full characterisation. This allowed the innovation partners to build the value proposition for their technology as they target their next commercial milestone.

  • Case Study 5

    Post-surgical wound healing

    The Customer

    A listed medical device company developing novel technologies for wound care.

    The Project

    To assist the company with the final design, development, tool building and small to large scale manufacture of components used in a medical device to be exported around the world.

    The Outcome

    Several meetings were held with the customer's project team at DEC to understand the customer's expectations, user requirements, critical quality attributes, milestones, budgets and timelines. DEC worked closely alongside the customer's project team to help them refine the design of the components for optimal manufacturing efficiency (Design for Manufacture). DEC managed the tool building project, sourcing quotes from multiple tool building companies, and validated the tools at DEC for medical device manufacturing on thermoplastic and silicon moulding machines. Parts are being supplied to the customer for ongoing development and commercialisation.

  • Case Study 6

    Dissolvable Intra-Rumen Bolus

    The Customer

    A start-up company developing a controlled feed-supplement release device in cows.

    The Project

    DEC was recommended to the customer as an ideal partner to work closely with them on design concepts, prototyping, iterative development, and tool building for components to be trialled at small scale, and to work with the company to help them scale production to much larger numbers. The component required a secondary filling and finishing step under ISO13485 compliance.

    The Outcome

    Several meetings were held with the customer's project team to understand the customer's expectations, user requirements, critical quality attributes, milestones, budgets and timelines. DEC worked closely alongside the customer's project team to help them refine the design of the components for optimal manufacturing efficiency (Design for Manufacture). DEC managed the tool building project, sourcing quotes from multiple tool building companies. DEC was able to produce components of the tool within a few days of receiving the tool. The customer is using these parts in animal trials and will use DEC’s services to fill and finish the components during manufacturing scale up.

  • Case Study 7

    Automated moulding and product assembly

    The Customer

    Established Dairy Product Manufacturer.

    The Project

    Automated manufacture, and assembly, of RF-ID tagged liquid sample vials.

    The Outcome

    DEC worked with the customer to design a six-cavity tool for large-scale injection moulding of single-use sample vials for laboratory testing. During manufacture two lids on the vials needed to be sealed, and an RF-ID tag installed for data tracking and custody control. A fully automated production and packing line was designed with a third party to rapidly read and sort good and bad/damaged tags, and insert them into the sample vials immediately following vial moulding.

  • Case Study 8

    Novel milk immersed biosensor

    The Customer

    A start up company developing novel biosensor technologies.

    The Project

    Mastitis leads to tainting of the milk, and is not measured until after all milk was collected in the tank, leading to huge milk waste. New sensor technology to measure somatic cells in the milk lines is needed to monitor milk in real time. An innovative concept was developed by our partners, which needed development and manufacture.

    The Outcome

    DEC partnered in the technology and developed the design for manufacture product, then scaled manufacture from small batches to large scale sensors now used in the industrial milk tool-chain of Fonterra and others. Electronic parts were sourced from a third party supplier.

Menu